Eton Pharmaceuticals, Inc. (ETON)
16.90
+0.49
(+2.99%)
USD |
NASDAQ |
Dec 11, 16:00
16.90
0.00 (0.00%)
After-Hours: 18:22
Eton Pharmaceuticals EPS Diluted (Quarterly): -0.0716 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Sanara MedTech, Inc. | -3.517 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
| Palatin Technologies, Inc. | 4.258 |
| Theriva Biologics, Inc. | -0.4507 |
| Oragenics, Inc. | -1.965 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.927M |
| Revenue (Quarterly) | 22.46M |
| Total Expenses (Quarterly) | 24.39M |
| Enterprise Value | 433.83M |
| Gross Profit Margin (Quarterly) | 34.97% |
| Profit Margin (Quarterly) | -8.58% |
| Earnings Yield | -1.47% |
| Normalized Earnings Yield | -1.334 |